Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Equity: 2018-2025

Historic Return on Equity for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to -0.88%.

  • Arcus Biosciences' Return on Equity fell 43.00% to -0.88% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.88%, marking a year-over-year decrease of 43.00%. This contributed to the annual value of -0.60% for FY2024, which is 5.00% down from last year.
  • Per Arcus Biosciences' latest filing, its Return on Equity stood at -0.88% for Q3 2025, which was down 14.23% from -0.77% recorded in Q1 2025.
  • In the past 5 years, Arcus Biosciences' Return on Equity ranged from a high of 0.11% in Q3 2022 and a low of -0.88% during Q3 2025.
  • Moreover, its 3-year median value for Return on Equity was -0.52% (2024), whereas its average is -0.55%.
  • As far as peak fluctuations go, Arcus Biosciences' Return on Equity surged by 60bps in 2022, and later crashed by 65bps in 2023.
  • Arcus Biosciences' Return on Equity (Quarterly) stood at 0.08% in 2021, then tumbled by 47bps to -0.39% in 2022, then decreased by 23bps to -0.63% in 2023, then rose by 9bps to -0.54% in 2024, then tumbled by 43bps to -0.88% in 2025.
  • Its last three reported values are -0.88% in Q3 2025, -0.77% for Q1 2025, and -0.54% during Q4 2024.